Topic Archives: Memory Pharmaceuticals

Comments

  • Here is an excerpt about Sulat from a 2015 $ARTH press release: 'FRAMINGHAM, MA -- (Marketwired) -- 08/20/15 -- Arch Th...

  • $ARTH new board appointment: Press Release today Arch Therapeutics Appoints James Sulat to Board of Directors Dow...

  • Press release from $ARCH - "Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of the AC5 Surgi...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info